NEW: DROPLET GENERATOR CHIPS FOR THE FLUIDIC CONNECT PLATFORM Enschede, The Netherlands – The generation of microsized droplets is gaining more and more attention from researchers in life-sciences, chemistry, material sciences, cosmetics, and food research. These droplets have a size in the order of a tenth of the diameter of a human hair and posses [...]

MOUNTAIN VIEW, Calif.--Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk and drug response, announced today that its BREVAGen™ breast cancer risk stratification test is now clinically available in select U.S. markets. Perlegen plans to add sales areas to make the test available nationwide over the next few months. Perlegen designed [...]

Psilos Group Leads Round to Fuel Growth of Proprietary Imaging System for Improved Detection of Breast Cance NORTHRIDGE, CA-- Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it had closed a $24 million financing, the company's first institutional round, in order to support continued growth of the company's [...]

CHI Next Generation Sequencing Meetings CAMBRIDGE, Mass.--Helicos BioSciences Corporation (NASDAQ: HLCS) provided updates on recent scientific findings and progress on Helicos’s technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation Sequencing conference in Providence, RI, Patrice Milos, Ph.D. Vice President and Chief Scientific Officer provided an [...]

SoluLinK Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100% Yields SAN DIEGO -- SoluLinK, Inc., a leader in quality conjugation products and services, introduces the TurboLink Conjugation Catalyst, making conjugation at least 20 times faster than before with 100% conjugate yields for antibodies, oligos, peptides and proteins. Up to now, [...]

In addition, QIAGEN unveils for the first time its companion diagnostic pipeline, which the Company believes is unmatched in terms of depth and profile VENLO, The Netherlands - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has acquired DxS Ltd (DxS), a privately-held developer and manufacturer of companion diagnostic products headquartered [...]

Agilent Technologies, Life Technologies Co-Market Target-Enrichment System for Next-Generation Sequencing SANTA CLARA, Calif. & CARLSBAD, Calif -- Agilent Technologies Inc. (NYSE:A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ:LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a next-generation advanced genomic analysis sequencing platform. As part of [...]

Definiens is Developing an Application Marketplace for Earth Sciences Professionals Munich, Germany / Parsippany, New Jersey – Definiens, the number one Enterprise Image Intelligence® company, today announced a new strategic direction for its Earth Sciences division. Definiens is building upon the success of its object-based image analysis (OBIA) platform to simplify the development and distribution [...]

StemCells, Inc. Announces Initiatives to Advance Cell-Based Technologies for Pharmaceutical Industry and Research Applications PALO ALTO, Calif.--StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and [...]

Agilent Technologies Adds Human Exon Kit to Next-Generation-Sequencing Target Enrichment Portfolio Support of Paired-End Protocol Further Increases Sequencing Efficiency PROVIDENCE, R.I.--Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute’s Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing. This catalog kit extends [...]